July 8, 2026
One year after the passage of the landmark reconciliation legislation colloquially dubbed "The One Big Beautiful Bill," the American healthcare landscape stands at a precarious juncture. While the bill was celebrated by its sponsors as a cornerstone of legislative reform, the reality of its implementation is currently unfolding within the bureaucratic corridors of the Centers for Medicare & Medicaid Services (CMS).
As the agency moves through the high-stakes rulemaking process, stakeholders in the behavioral health and addiction recovery sectors are sounding alarms. The proposed regulations, if finalized, threaten to impose restrictive work requirements on Medicaid recipients and slash reimbursement rates for critical services through new caps on State Directed Payments (SDPs). For the millions relying on Medicaid for substance use disorder (SUD) treatment and recovery support, these rules represent a potential rollback of hard-won access to care.
Chronology: From Legislative Triumph to Regulatory Complexity
The journey to the current crisis began in mid-2025, when Congress passed the reconciliation package amidst significant political fanfare. The bill aimed to streamline federal spending, yet its structural changes to Medicaid—the largest source of coverage for low-income Americans—were sweeping.
- July 2025: "The One Big Beautiful Bill" is signed into law, initiating a massive restructuring of Medicaid delivery systems.
- Late 2025 – Early 2026: CMS initiates the formal rulemaking process. This phase is designed to translate legislative intent into actionable policy, providing the specific parameters by which states must operate.
- Spring 2026: As the nuances of the proposed rules emerge, advocacy groups, including the Legal Action Center and the Coalition for Whole Health, identify "red flags" regarding work requirements and provider payment caps.
- July 2026 (Current): The public comment period is active, with health advocacy organizations mobilizing to challenge provisions that threaten the stability of the recovery support ecosystem.
The Regulatory Squeeze: Work Requirements and the "Medically Frail"
The most contentious aspect of the proposed rule concerns work requirements for the "ACA expansion population"—individuals who gained Medicaid eligibility specifically through the Affordable Care Act’s expansion.
The Illusion of Exemption
The government has maintained that there are safety nets for vulnerable populations, specifically the "Medically Frail" exemption. On paper, this is designed to protect those whose physical or behavioral health conditions prevent them from maintaining traditional employment. To qualify, an individual must fit into one of five categories:
- Being blind or disabled.
- Suffering from a substance use disorder (SUD).
- Living with a disabling mental health condition.
- Having a physical, intellectual, or developmental disability.
- Managing a serious or complex medical condition.
However, advocates argue that the new rule introduces a "demonstration burden." It is no longer sufficient to carry a diagnosis; recipients must now actively prove an impaired capacity to meet work requirements. This adds a layer of administrative friction that often results in the unintended termination of coverage for those most in need.
The Five-Year Recovery Fallacy
Furthermore, the proposed rule includes an exemption for those participating in qualifying SUD treatment programs. Crucially, the government has proposed excluding individuals who have been in recovery for five years or more. The rationale provided by the rule—that these individuals are at no higher risk for relapse than the general population—is being challenged by the clinical community.
"The assertion that someone five years into recovery has zero vulnerability is a fundamental misunderstanding of the chronic, relapsing nature of addiction," says a representative from the Coalition for Whole Health. By setting an arbitrary five-year limit, the rule threatens to force long-term, stable individuals out of the Medicaid program, potentially triggering the very instability they have worked so hard to overcome.
State Directed Payments (SDP) and the Threat to Provider Viability
Beyond the impact on patients, the rule poses a systemic threat to the institutions that provide care. State Directed Payments (SDPs) have historically been a vital tool for states to incentivize Managed Care Organizations (MCOs) to prioritize SUD services. By allowing states to set minimum payment rates, SDPs ensured that providers—who often operate on thin margins—remained solvent and willing to accept Medicaid patients.
The Shift to Medicare-Linked Caps
The 2025 law introduced new limits on SDPs, capping them at or near Medicare rates. While the legislation specifically targeted inpatient and outpatient hospital services, nursing facilities, and academic medical centers, the proposed rule goes significantly further. CMS intends to apply these caps to all Medicaid services.
For the recovery community, this is catastrophic. Many recovery support services lack direct equivalents in the Medicare coding system. Because Medicare reimbursement is often lower than the true cost of delivering intensive, specialized recovery care, forcing these services to align with Medicare-linked caps will effectively result in deep, permanent rate cuts. This risks a "provider exodus," where community-based organizations, unable to cover their overhead, are forced to close their doors or discontinue Medicaid-funded services.
Implications for the Recovery Ecosystem
The cumulative effect of these rules is a potential shrinking of the recovery safety net. If providers are squeezed by rate cuts and patients are bogged down by administrative work requirements, the predictable result is a decrease in access to care.
The Risk of Fragmentation
The Legal Action Center has highlighted that the complexity of these rules will disproportionately affect those with the fewest resources. Individuals struggling with SUD often face comorbidities—housing instability, transportation challenges, and cognitive deficits—that make navigating a complex, requirements-heavy Medicaid system nearly impossible.
The Economic Argument
While the federal government aims to reduce costs through these restrictions, the long-term economic impact is likely to be negative. Untreated substance use disorders frequently lead to increased utilization of emergency departments, involvement with the criminal justice system, and long-term disability, all of which represent higher costs to the state than providing consistent, outpatient recovery support.
Official Responses and the Path Forward
The advocacy community is not standing idle. The Legal Action Center, in partnership with the Coalition for Whole Health, is preparing comprehensive comments to be submitted to CMS. Their goal is to force a reconsideration of the most punitive aspects of the rule.
"We are essentially working to educate the regulators on the ground-level reality of addiction treatment," said one policy analyst involved in the effort. "The math of the rule looks good on a spreadsheet, but in a clinical setting, it is a recipe for patient abandonment."
Key points of the upcoming advocacy response include:
- Removal of the 5-Year Threshold: Demanding that recovery status be recognized as a lifelong, albeit manageable, condition, removing the artificial five-year expiration on work exemptions.
- Flexibility for SUD Services: Requesting that CMS exempt recovery support services from the restrictive Medicare-linked SDP caps, acknowledging that these services are distinct from traditional medical hospital services.
- Streamlining Eligibility: Proposing that the "Medically Frail" status be determined by simple clinical attestation rather than an exhaustive, time-consuming administrative review.
Conclusion
As the comment period continues, the future of the American recovery support system hangs in the balance. "The One Big Beautiful Bill" was intended to improve the healthcare system, but as the rulemaking process reveals, the path to reform is fraught with unintended consequences.
For the millions of Americans in active recovery, the next few months will be decisive. The outcome of the CMS rulemaking process will determine whether Medicaid remains a robust partner in the fight against the addiction crisis or whether it becomes a system defined by barriers, gaps, and lost opportunities. Advocacy groups remain steadfast in their mission: to ensure that federal policy reflects the realities of the patients it is designed to serve, not just the fiscal goals of the regulators who govern them.
